Mutant IDH1: An immunotherapeutic target in tumors
Theresa Schumacher(German Cancer Research Center), Lukas Bunse(German Cancer Research Center), Wolfgang Wick(German Cancer Research Center), Michael Platten(German Cancer Research Center)
Cited by 30Open Access
Abstract
antitumor T cell response in patients and a syngeneic tumor model in MHC-humanized mice.
Related Papers
Tumor-reactive CD4+ T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts
Sergio A. Quezada, Tyler R. Simpson, Karl S. Peggs et al.|The Journal of Experimental Medicine|2010|878